← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Barnes-Jewish Hospital
Saint Louis, MO
$47,015,970
Total funding
109
Grants
Funding over time
peak $202.1K · FY2006–17$250K$187.5K$125K$62.5K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$47,015,970 · 106
AHRQ$0 · 2
CDC$0 · 1
By mechanism
R01$34,863,345 · 67
P01$6,391,522 · 16
U01$1,652,459 · 2
N01$727,381 · 2
K08$580,515 · 3
R03$571,383 · 6
Investigators at Barnes-Jewish Hospital
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Largest grants
MECHANISMS IN THE REMODELING OF LUNG STRUCTURE$1,423,256
P01 · FY2002 · HL
MECHANISMS IN THE REMODELING OF LUNG STRUCTURE$1,403,181
P01 · FY2001 · HL
MECHANISMS IN THE REMODELING OF LUNG STRUCTURE$1,344,965
P01 · FY2000 · HL
BIOLOGY OF CELL/CELL COMMUNICATION IN BONE$1,296,605
P01 · FY2001 · AR
BIOLOGY OF CELL/CELL COMMUNICATION IN BONE$1,275,370
P01 · FY2000 · AR
PATHOPHYSIOLOGY OF RENAL DISEASE$996,591
P01 · FY2002 · DK
PATHOPHYSIOLOGY OF RENAL DISEASE$972,444
P01 · FY2001 · DK
PATHOPHYSIOLOGY OF RENAL DISEASE$948,999
P01 · FY2000 · DK
NOVEL TECHNOLOGIES FOR NONINVASIVE DETECTION, DIAGNOSIS$727,381
N01 · FY2000 · CO
Mechanisms of Orthopedic Implant Osteolysis$598,148
R01 · FY2002 · AR
MICROSCOPIC CARDIAC MATERIAL PROPERTIES IN AGING$444,376
R01 · FY2002 · HL
Specific Tissue Targeted Ultrasonic Contrast Agent$434,259
R01 · FY2002 · HL
MICROSCOPIC CARDIAC MATERIAL PROPERTIES IN AGING$433,602
R01 · FY2001 · HL
RESEARCH FOR ELIMINATION OF HUMAN FILARIASIS$426,167
U01 · FY2000 · AI
RESEARCH FOR ELIMINATION OF HUMAN FILARIASIS$424,336
U01 · FY2001 · AI
MICROSCOPIC CARDIAC MATERIAL PROPERTIES IN AGING$423,143
R01 · FY2000 · HL
RESEARCH FOR ELIMINATION OF HUMAN FILARIASIS$420,628
U01 · FY2002 · AI
Protein Z Dependent Proteinase Inhibitor$393,278
R01 · FY2002 · HL
Specific Tissue Targeted Ultrasonic Contrast Agent$384,057
R01 · FY2001 · HL
SPASTICITY AND STRENGTH AS INDICATORS FOR RHIZOTOMY$380,353
R01 · FY2000 · NS